Summary
- Current Price
- As of today, RYTM price is $86.97, down -1.31% in the most recent trading session on
- Current Price All-Time High
- RYTM price is currently -28.83% below its historical high of $122.20 set on
- Market Cap
- RYTM current market cap is $6B, up +75.91% over the past 365 days
- PE Ratio
- RYTM PE ratio is unknown
- Revenue
- RYTM current annual revenue is $189.76M, up +45.83% year-over-year
- Next Earnings
- The next earnings release for RYTM is on
Profile
| Metric | Value |
|---|---|
| Full Name | Rhythm Pharmaceuticals, Inc. |
| Ticker | NASDAQ: RYTM |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | rhythmtx.com |
| Employees | 283 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $86.97 | |
| Price, 1D Change | -1.31% | |
| $6B | ||
| - | ||
| - | ||
| 0.78 | ||
| $190M | ||
| Revenue, 1Y Change | +45.83% | |
| -$3.11 | ||
| EPS, 1Y Change | +28.37% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$3.11 | ||
| EPS Estimate | N/A | -$3.07 |
| EPS Est. Change | N/A | +1.08% |
| $189.76M | ||
| Revenue Estimate | N/A | $288.02M |
| Revenue Est. Change | N/A | +51.78% |
| Current Price | $86.97 | |
| Price Target | - | $140.00 |
| Price Tgt. Change | - | +60.98% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$4.07 | -$4.34 | -6.57% | |
| -$3.11 | -$3.11 | +0.18% | |
| -$3.07 | N/A | +1.08% | |
| -$0.33 | N/A | +89.46% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $126.95M | $130.13M | +2.50% | |
| $188.98M | $189.76M | +0.41% | |
| $288.02M | N/A | +51.78% | |
| $537.12M | N/A | +183.06% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $86.97 | |
| $96.87 | ||
| SMA 200 vs Price | +11.39% | |
| $95.55 | ||
| SMA 50 vs Price | +9.88% | |
| 0.78 | ||
| $5.70 | ||
| 49.11 | ||
| 89.55% | ||
| 60.52% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $189.76M | ||
| -$3.11 | ||
| $170.27M | ||
| 89.50% | ||
| -$192.02M | ||
| -101.19% | ||
| -$196.54M | ||
| -103.57% | ||
| -$190.68M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.97 | ||
| 4.41 | ||
| 4.16 | ||
| - | ||
| 5 | ||
| 6.22 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 30.58 | ||
| 41.73 | ||
| -29.67 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $139.07M | ||
| $388.95M | ||
| $481.19M | ||
| $466.92M | ||
| $342.13M | ||
| $105.94M | ||
| $134.95M | ||
| $650.00K | ||
| $13.95M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $386.30M | ||
| $362.28M | ||
| $19.49M | ||
| $194.94M | ||
| $1.34M | ||
| $0.00 | ||
| $497.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$115.68M | ||
| -$137.15M | ||
| $217.96M | ||
| $40.95M | ||
| -$156.63M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| Citizens | → | |
| Citigroup | → | |
| B of A Securities | → | |
| HC Wainwright & Co. | → | |
| RBC Capital | → | |
| Needham | → | |
| Morgan Stanley | → | |
| Citizens | → | |
| Citigroup | → |
Analyst sentiment
Institutional ownership
Screeners with RYTM
FAQ
What is the ticker symbol for Rhythm Pharmaceuticals, Inc.?
The ticker symbol for Rhythm Pharmaceuticals, Inc. is NASDAQ:RYTM
Does Rhythm Pharmaceuticals, Inc. pay dividends?
No, Rhythm Pharmaceuticals, Inc. does not pay dividends
What sector is Rhythm Pharmaceuticals, Inc. in?
Rhythm Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Rhythm Pharmaceuticals, Inc. in?
Rhythm Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Rhythm Pharmaceuticals, Inc. based in?
Rhythm Pharmaceuticals, Inc. is headquartered in United States
When did Rhythm Pharmaceuticals, Inc. go public?
Rhythm Pharmaceuticals, Inc. initial public offering (IPO) was on October 9, 2017
Is Rhythm Pharmaceuticals, Inc. in the S&P 500?
No, Rhythm Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Rhythm Pharmaceuticals, Inc. in the NASDAQ 100?
No, Rhythm Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Rhythm Pharmaceuticals, Inc. in the Dow Jones?
No, Rhythm Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Rhythm Pharmaceuticals, Inc. last earnings report?
Rhythm Pharmaceuticals, Inc.'s most recent earnings report was on February 26, 2026
When does Rhythm Pharmaceuticals, Inc. report earnings?
The next expected earnings date for Rhythm Pharmaceuticals, Inc. is May 6, 2026
Data Sources & References
- RYTM Official Website rhythmtx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1649904/000162828026012399/0001628280-26-012399-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1649904/000162828026012399/0001628280-26-012399-index.htm
- RYTM Profile on Yahoo Finance finance.yahoo.com/quote/RYTM
- RYTM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rytm